Piperidines
eMolecules 41838-46-4 | 4-Amino-1-methylpiperidine | Apollo Scientific | MFCD01570549 | 114.192 | C6H14N2 | 92.000 | CN1CCC(N)CC1 | 5g | 600855825
4-Amino-1-methylpiperidine | Apollo Scientific | 41838-46-4 | MFCD01570549 | 114.192 | C6H14N2 | 92.000 | CN1CCC(N)CC1 | 5g | 600855825
Apexbio Technology LLC Amodiaquine dihydrochloride dihydrate 6398-98-7 500mg
Amodiaquine dihydrochloride dihydrate (CAS 6398-98-7) is a small-molecule inhibitor targeting histamine N-methyltransferase (HNMT) It is designed to inhibit HNMT thereby affecting intracellular histamine metabolism Amodiaquine dihydrochloride dihydrate exerts its biological activity primarily through inhibition of HNMT In biochemical assays involving rat kidney-derived HNMT amodiaquine demonstrates inhibitory activity with a reported Ki value of approximately 18 6 nM Based on these pharmacological properties amodiaquine dihydrochloride dihydrate holds research potential in investigating histamine metabolism pathways in inflammatory disease models
Medchemexpress LLC K-Ras-PDE -IN-1 5mg | 1841464-21-8 | 447.50 g/mol | C25H26FN5O2 | 5 MG
K-Ras-PDEδ-IN-1 is a small-molecule competitive inhibitor that binds the farnesyl binding pocket of PDEδ and disrupts PDEδ-K-Ras interaction. It is provided for research use in biochemical and cellular studies and is characterized by nanomolar affinity and high chemical purity. Follow supplier solubility and handling guidance when preparing solutions for in vitro or in vivo use.
- Binds the PDEδ farnesyl pocket with a Kd of ~8 nM.
- High chemical purity (≈99.6% as supplied).
- Soluble in DMSO (12.5 mg/mL); ultrasonic recommended for dissolution.
- Formulation guidance provided for in vivo suspension (10% DMSO, 40% PEG300, 5% Tween-80, 45% saline).
- Available in small research pack sizes suitable for biochemical assays.
Aobchem 4-Propoxyphenylboronic acid pinacol ester | ≥97% | CAS 1374430-02-0 | C15H23BO3 | 5g
4-Propoxyphenylboronic acid pinacol ester | ≥97% | CAS 1374430-02-0 | C15H23BO3 | 5g
Selleck Chemical LLC Ceritinib
Ceritinib is a potent inhibitor against ALK with IC50 of 0 2 nM in cell-free assays Ceritinib (LDK378) also inhibits IGF-1R InsR STK22D and FLT3 with IC50 of 8 nM 7 nM 23 nM and 60 nM respectively Phase 3
eMolecules 70665-05-3 | (S)-2-Phenylpiperidine | Key Organics/BIONET | MFCD00270125 | 161.248 | C11H15N | 97.000 | C1CCC(NC1)c1ccccc1 | 1mg | 564145614
(S)-2-Phenylpiperidine | Key Organics/BIONET | 70665-05-3 | MFCD00270125 | 161.248 | C11H15N | 97.000 | C1CCC(NC1)c1ccccc1 | 1mg | 564145614
![Medchemexpress LLC 4-[6-[[4-(cyclopropylmethyl)piperazin-1-yl]methyl]-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine | 955977-50-1 | 99.0% | 10MM 1ML](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000231443.png-250.jpg)
Medchemexpress LLC 4-[6-[[4-(cyclopropylmethyl)piperazin-1-yl]methyl]-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine | 955977-50-1 | 99.0% | 10MM 1ML
4-[6-[[4-(cyclopropylmethyl)piperazin-1-yl]methyl]-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine | 955977-50-1 | 99.0% | 10MM 1ML
Medchemexpress LLC BI-9627 hydrochloride | 1422252-46-7 | 98.0% | 392.80 g/mol | C16H20ClF3N4O2 | 10 MG
BI-9627 hydrochloride is the hydrochloride salt of a potent sodium-hydrogen exchanger 1 (NHE1) inhibitor supplied for research use. The compound is intended for biochemical and pharmacological studies of NHE1 activity and is accompanied by analytical documentation to support quality and identity.
- Potent NHE1 inhibition at low nanomolar concentrations.
- Hydrochloride salt form improves solubility for formulation and handling.
- High purity suitable for research applications and analytical studies.
- Characterized molecular weight 392.80 g/mol and formula C16H20ClF3N4O2.
- Supplied with supporting documentation such as COA and analytical data.